Buscar resultados de ensayos clínicos
Purpura, Thrombocytopenic, Idiopathic - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP) Condición: Purpura, Thrombocytopenic, Idiopathic Fecha: 2008-06-25 Intervenciones: Drug: Fostamatinib Disodium / R935788 R935788 tablets |
Completed |
Nombre del estudio: Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP) Condición: Purpura, Thrombocytopenic, Idiopathic Fecha: 2006-09-06 Intervenciones:
|
Completed |
Nombre del estudio: Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT) Condición: Purpura, Thrombocytopaenic, Idiopathic Fecha: 2007-01-17 Intervenciones: Drug: eltrombopag experimental |
Completed |
Nombre del estudio: A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients Condición: Purpura, Thrombocytopenic, Idiopathic Fecha: 2015-03-20 Intervenciones: Drug: Hetrombopag Olamine Hetrombopag Olamine 2.5mg, 5mg and 7.5mg |
Terminated |
Nombre del estudio: Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP). Condición: Purpura, Thrombocytopenic, Idiopathic Fecha: 2013-12-09 Intervenciones: Drug: BI 655064 subcutaneous injection |
Completed |
Nombre del estudio: Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condición:
|
Completed |
Nombre del estudio: High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) Condición: Purpura, Thrombocytopenic, Idiopathic Fecha: 2011-05-17 Intervenciones:
|
Withdrawn |
Nombre del estudio: A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia. Condición: Purpura, Thrombocytopaenic, Idiopathic Fecha: 2011-09-22 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP) Condición: Immune Thrombocytopenia Fecha: 2016-12-22 Intervenciones: Drug: Bortezomib Bortezomib was given by intravenous bolus injection at a dose of 1.3 mg/m2 on days 1, 4 |
Completed |
Nombre del estudio: Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia Condición: Purpura, Thrombocytopenic, Idiopathic Fecha: 2015-01-06 Intervenciones:
|